Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Dose reduction”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 289 records · Page 16Linked to original sources

Detection of coronary calcifications: feasibility of dose reduction with a body weight-adapted examination protocol.

OBJECTIVE: The purpose of this study was to assess the applicability of individual body weight-adapted tube current time settings in multidetector CT for detection of coronary calcifications and to evaluate the effect of reducing the radiation dose on the coronary calcium score. SUBJECTS AND METHODS. One hundred patients underwent retrospectively ECG-gated MDCT for detection of coronary calcifications. First, fixed tube current time settings were used in 50 patients. Second, image noise corresponding to body weight-adapted tube current time settings was added to these images. Finally, body weight-adapted tube current time settings were applied to another 50 patients. For each patient group, the radiation dose was calculated. Coronary calcium scores were compared for the patient groups with the fixed tube current time settings with and without artificially added image noise. In all image series, image noise was assessed by a region-of-interest methodology. Image noise was analyzed using a regression analysis. RESULTS: The effective radiation dose was reduced by 11.6% for men and 24.8% for women using the body weight-adapted tube current time settings. There were no statistically significant changes in the coronary calcium score after the addition of artificial image noise (p = 0.84). Adaptation of the tube current time settings did not lead to a relevant increase in image noise. The radiation doses for the plotted noise-to-body weight (slope, 0.081) and noise-to-body mass index (slope, 0.378) ratios for the standard protocol proved relatively high for patients of lower weight. An improved noise-to-body weight (slope, 0.054) and noise-to-body mass index (slope, 0.190) ratio was achieved by application of the body weight-adapted tube current time settings, resulting in nearly constant image noise related to body weight. CONCLUSION: Individual body weight-adapted current time settings are applicable for coronary calcium scoring without a change of the coronary calcium score or relevant increase of the image noise.

Body Mass Index↗

Thickness of shielding required for dose reduction with 4-22 MeV electrons.

In electron therapy, it is common practice to shape the treatment area by the use of lead or cerroband alloy on the skin, or as insert at the electron collimator. We have studied the effect of the position of these shields on the skin dose and the thickness of the shield to reduce the dose to less than 5%. With energies above 12 MeV, it is not practicable to reduce the dose to 5% or less with reasonable thickness of the shield at either position. For lower energies the shield is more effective at the collimator rather than on the skin.

Electrons↗

Dose reduction in mammography.

Two mammographic imaging systems (Xerox and Kodak Min-R) were evaluated. Three hundred consecutive mammographic examinations were performed utilizing both imaging systems. Results of these studies indicated equivalency of image detail at identical source-to-image receptor distance (SID). Patient exposure as measured by the thermoluminescent dose meter for Kodak Min-R system was approximately 25% that of Xeromammography system. Due to reduced power requirement, it is possible to increase the SID when Min-R system is employed for imaging. Improved geometric arrangement provided superior diagnostic images in 5.5% of 200 comparison cases.

Female↗

Patient dose reduction in CT examinations by optimising scanogram acquisition.

The objective was to determine the optimum settings of the scanogram performed in computed tomography (CT) examinations for scan localisation. Head, abdomen and thorax scanograms were performed on a Rando anthropomorphic phantom using various selectable combinations of tube voltage and tube current values. Thermoluminescence dosemeters were used to obtain entrance skin dose data. Effective dose was estimated using normalised organ dose data provided by the National Radiological Protection Board. One hundred and twelve head, 114 thoracic and 111 abdominal patient scanograms were obtained with lower settings than those recommended by the operator's manual. Scanogram sufficiency was assessed by four observers. Head and thoracic scanograms obtained with 80 kV/50 mA and abdominal scanograms obtained with 80 kV/75 mA were found to be acceptable, even though the operator's manual recommendation was 120 kV/100 mA. Thus, the scanogram effective dose was reduced by 72%, 84% and 88% for head, thorax and abdomen examination respectively. Effective dose from a complete CT examination may be reduced by up to 3.5% without any subsequent image quality degradation of the diagnostically important sectional images.

Abdomen↗

Digital radiography in urologic imaging: radiation dose reduction on urethrocystography.

Digital luminescent radiography (DLR) is a new form of digital radiographic technology which can be used as an alternative to conventional radiologic systems; it replaces conventional screen-film systems by photostimulable phosphorus. Due to the linear dynamic range of photostimulable phosphorus, x-ray examinations can be performed with significantly lower radiation exposure. In this study radiation dose was reduced by about 90% using DLR for urethrocystography.

Humans↗

Improving the efficacy of BCG immunotherapy by dose reduction.

Several clinical trials have shown intravesical bacillus Calmette-Guérin (BCG) to be effective in the prophylaxis of papillary tumour recurrences and in the therapy of bladder carcinoma in situ (CIS), as well as in delaying progression to muscle invasion. Nevertheless, the optimal regimen of BCG therapy for superficial bladder cancer has still to be defined. In a previous phase II trial, a low-dose regimen (BCG Pasteur strain, 75 mg) was able to achieve clinically significant response rates with a decrease in side-effects compared with other reported studies using standard-dose BCG. However, a phase III randomized trial--low dose versus standard dose (BCG Pasteur strain, 75 vs. 150 mg)--was considered necessary to clarify definitively the relationships between dose, efficacy and toxicity. The results of the interim analysis of 183 patients (performed in 1993) have shown response rates to be better in patients submitted to a low-dose BCG regimen (p = 0.0009) and a significant decrease in most of the common side-effects (cystitis, fever, haematuria; p < 0.05). Breaking down the results by stage, no differences in response rates were found in patients with stage TaM (70 vs. 62% in low-dose and standard-dose regimens, respectively, p = 0.5). In T1M and CIS stages, 82 and 0 (p = 0.07), and 64 and 0% (p = 0.0003) of patients were free of tumour following low-dose and standard-dose therapy, respectively. An additional 6-week course in patients who failed the induction course retrieved additional responses in both groups. No differences in progression rates were observed.(ABSTRACT TRUNCATED AT 250 WORDS)

Administration, Intravesical↗

Dose reduction in pediatric CT: a rational approach.

PURPOSE: To determine size-dependent technique factors for pediatric computed tomography (CT) by using physically measured objective data. MATERIALS AND METHODS: Six phantom cylinders (10-32 cm in diameter) were scanned with a clinical multi-detector row CT scanner. CT noise was statistically characterized for CT technique factors from 80 to 140 kVp and from 10 to 300 mAs. Dose measurements were performed with each phantom. Dilute iodine and tissue contrast were determined with computer calculations validated with measured data. The dose, noise, and contrast data were computer fit, and pediatric CT technique factors (milliampere seconds) necessary to maintain the contrast-to-noise ratio (CNR) were computed. RESULTS: As compared with that in a reference cylindric adult abdomen of 28 cm in diameter, CNR was maintained at a constant level in pediatric patients of 25, 20, and 15 cm in diameter, respectively, when milliampere second values of 0.557, 0.196, and 0.054 of the adult milliampere second values were used. The corresponding doses were reduced to 0.642, 0.287, and 0.090 of the 28-cm-diameter adult dose, respectively. CT techniques for examination of pediatric heads measuring 15 and 13 cm, respectively, can involve the use of milliampere second values of 0.572 and 0.366 of those used for examination of a standard 17-cm-diameter adult head. CONCLUSION: CT technique charts for pediatric abdominal and head examinations were produced on the basis of physically measured data; use of these tables will enable pediatric radiation dose to be reduced while CNR is preserved.

Adult↗

Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines.

Folinic acid (FA) and cisplatin (CDDP) both potentiate the cytotoxicity of 5-fluorouracil (5-FU). The activity of various drug combinations including 5-FU, CDDP and FA was tested on two human cell lines derived from squamous cell carcinomas of the head and neck. Cytotoxicity was assessed by the semi-automated colorimetric MTT test. The drugs were tested in clinically achievable conditions (concentrations and duration of exposure). The dose response curves for 5-FU (0-100 ng ml-1) associated with FA (10(-7)-10(-5) M) reflected a progressive increase in 5-FU cytotoxicity with increasing FA concentrations. When CDDP (0-5 micrograms ml-1) was associated with 5-FU, CDDP-mediated enhancement of 5-FU cytotoxicity was apparent only when CDDP was given before 5-FU. The triple association CDDP, 5-FU and FA was also tested. In this case, for an identical final cytotoxicity, the presence of FA (10(-6) M) permitted reduction of the 5-FU concentration between 24.2 and 42% and reduction of the CDDP concentration between 13.8 and 72.7%. These observations may be beneficial for the design of more rational therapeutic trials associating CDDP, 5-FU and FA.

Antineoplastic Combined Chemotherapy Protocols↗

Radiation exposure and projected risks with multidetector-row computed tomography scanning: clinical strategies and technologic developments for dose reduction.

A substantial increase in computed tomography (CT) scanning with availability of state-of-the-art multidetector-row CT scanners has generated debate about its safety and considerable interest in formulating clinical and technologic strategies to reduce radiation exposure. This review describes the magnitude of radiation exposure associated with CT scanning and projected radiation risks as well as clinical strategies and major technologic innovations for reducing radiation dose to patients undergoing CT scanning.

Humans↗

Prediction of response to haloperidol dose reduction by Span of Apprehension measures for treatment-refractory schizophrenic patients.

Thirteen treatment-refractory schizophrenic patients participated in a haloperidol reduction study. Two of the subjects were unable to tolerate medication reduction. These subjects were comparable to the other patients in terms of initial clinical variables but were outliers on baseline accuracy and reaction time measures from the Span of Apprehension. The results suggest that aspects of basic visual processing and motor response speed may identify patients who require higher neuroleptic doses.

Adult↗

Use of nandrolone decanoate as an adjuvant for erythropoietin dose reduction in treating anemia in patients on hemodialysis.

BACKGROUND/AIMS: Use of androgen as an adjuvant therapy to treat anemia in patients on hemodialysis is debated. Our target is to assess the safety and the efficacy of nandrolone decanoate (ND) as an effective adjunctive therapy to treat such anemia. METHODS: This study included 32 anemic adult hemodialysis patients who had adequate iron stores. They were randomized into two equal groups: the first group received subcutaneously a low dose of erythropoietin (EPO) 1,000 U three times weekly combined with ND, 50 mg intramuscularly twice weekly, and the second group received only the same low dose of EPO for the 6-month study period. All patients were subjected to a serial follow-up of hemoglobin (Hb), hematocrit % (Hct%), iron store indices, serum insulin-like growth factor-1 (IGF-1) concentration and liver function tests. RESULTS: A significant rise of both Hb and Hct in both groups was found at the end of the study (p < 0.001). Although the rise of both Hb and Hct was higher in the androgen group, it was not rated as being statistically significant. Both groups showed a significant rise of serum IGF-1 concentration at the end of the study in comparison to its initial value. Moreover, the androgen group attained a more statistically significant rise of IGF-1 serum concentration. Four female patients discontinued ND because of related adverse effects, principally distressing hirsutism and hepatic dysfunction. CONCLUSION: Addition of ND to a low-dose EPO regimen does not offer a significant benefit. Androgen-related side effects limit its use in female patients.

Adult↗

Radiation dose reduction without compromise of image quality in cardiac angiography and intervention with the use of a flat panel detector without an antiscatter grid.

OBJECTIVE: To test the hypothesis that replacing the antiscatter grid with an air gap will reduce patient radiation exposure without significant compromise of image quality. METHODS: 457 patients having either uncomplicated diagnostic studies or a single vessel angioplasty (percutaneous transluminal coronary angioplasty (PTCA)) on a flat plate system (GE Innova) were studied. For two months their total dose-area product score was recorded on standard gridded images and then for two months on images made with the grid out, with an air gap used to reduce scatter. Detector magnification was reduced one step when an air gap was used to achieve the same final image size. A sample set of studies was reviewed blind by five observers, who scored sharpness and contrast on a non-linear scale. RESULTS: The average dose-area product was significantly reduced, both in the diagnostic group (n = 276), from a mean (SD) of 26.2 (14.7) Gy.cm2 with the grid in to 16.1 (12) Gy.cm2 with the grid out (p = 0.01), and in the PTCA group (n = 181), from 48.2 (36.2) to 37 (27.5) (p = 0.01). The mean image quality scores of the gridless cohort were not significantly different from those of the gridded cohort. CONCLUSION: With the use of a flat plate detector, air gap gridless angiography reduces the radiation dose to the patient and, in consequence, to the operator without significantly affecting image quality. It is proposed that gridless imaging should be the default technique for adults and children and in most installations.

Cohort Studies↗

[X-ray dose reduction in examination of infant's hip with image-intensifier-fluoroscopy-system (author's transl)].

An image intensifier--70mm camera--fluoroscopy system combined with a conventional X-ray tube is used for routine examination of the infant's hip. The high quality of 85% of these 70mm exposures makes immediate diagnostic interpretation possible. An even higher percentage can be achieved by most exact positioning of the patients. Apart from the radiation protection of the gonades, the X-ray skin dose of the primary beam is reduced by 90-95% compared with full size radiography using film screen combinations. This exposure technique can certainly be used not only for the examination of the infant's hip.

Fluoroscopy↗

[Possibilities of dose reduction in extramammographic xeroradiography (author's transl)].

The soft radiation within the inhomogeneous spectrum of bremsstrahlung, being unable to penetrate the object and not contributing to the build-up of the xeroradiographic picture, only being the cause of additional radiation exposure, is considerably reduced by means of added filters, copper filters in particular. This effect can be demonstrated qualitatively by means of the recorded X-ray spectra. In comparison with the standard record it is possible by hardening of the radiation to reduce the surface dose by a factor 8 at a tube voltage of 120 kV, and by a factor 10 at a tube voltage of 130 to 150 kV if a 0.5 mm thick copper filter is added. The surface dose measured with high-filtration in xeroradiography is within the same order of magnitude as the dose obtained with a conventional film-foil-combination (Cronex 4/Cawo high-definition foil, 75 kV, automatic exposure control, time of development 90 s) and amounts to circa 0.1 R. A loss of information in so-called high-filtration xerograms as compared to conventional xerograms could be excluded, at least with regard to the test object. The practicability of this method e.g. for angiography, particularly angiographic exploration of the limbs, needs further clinical examination.

Angiography↗

Dose reduction improves hearing preservation rates after intracanalicular acoustic tumor radiosurgery.

OBJECTIVE: To assess the potential for long-term serviceable hearing preservation in intracanalicular acoustic tumor patients who underwent stereotactic radiosurgery. METHODS: Between August 1987 and December 1997, 29 patients with intracanalicular acoustic tumors underwent stereotactic radiosurgery at our center using the Leksell gamma knife (Elekta Instruments, Inc., Atlanta, GA). Fifteen assessable patients had serviceable preradiosurgery hearing (pure tone average, < or = 50 dB; speech discrimination score, > or = 50%). We retrospectively analyzed our hearing results and compared hearing preservation in patients who received a minimal tumor dose of 14 Gy or less versus those who received more than 14 Gy to the tumor margin. RESULTS: No perioperative patient morbidity or mortality was observed. Serviceable hearing was preserved in 11 (73%) of 15 assessable patients (actuarial rate, 65%). Long-term follow-up demonstrated serviceable hearing preservation in 10 (100%) of 10 patients who received marginal tumor doses of 14 Gy or less but in only one of five patients who received more than 14 Gy. Preradiosurgery Gardner-Robertson class was preserved in 49%, and testable hearing was present in 68% of patients who had any testable hearing at presentation. Five patients demonstrated improvement in hearing (three had serviceable and two had nonserviceable hearing before radiosurgery). No patient developed a facial or trigeminal neuropathy. Seven of 13 patients with preoperative tinnitus continued to experience tinnitus in follow-up. Episodic vertigo continued in 3 of the 11 patients who presented with vertigo. CONCLUSION: Gamma knife radiosurgery (using conformal dose planning, small-beam geometry, and < or = 14 Gy to the margin) prevents tumor growth and achieves excellent hearing preservation rates.

Audiometry, Pure-Tone↗